Relmada Therapeutics (RLMD) Misses Q2 EPS by 9c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| (NASDAQ: RLMD) | Delayed: 4.17 -0.1 (2.34%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.27 | 52 Week High | $4.10 | |||
| Open | $4.34 | 52 Week Low | $0.87 | |||
| Day High | $4.60 | P/E | N/A | |||
| Day Low | $4.11 | EPS | $0.00 | |||
| Volume | 2,635,237 | |||||
